WO1999004793A3 - Budipine s'utilisant dans le traitement d'affections inflammatoires du systeme nerveux - Google Patents

Budipine s'utilisant dans le traitement d'affections inflammatoires du systeme nerveux Download PDF

Info

Publication number
WO1999004793A3
WO1999004793A3 PCT/EP1998/004457 EP9804457W WO9904793A3 WO 1999004793 A3 WO1999004793 A3 WO 1999004793A3 EP 9804457 W EP9804457 W EP 9804457W WO 9904793 A3 WO9904793 A3 WO 9904793A3
Authority
WO
WIPO (PCT)
Prior art keywords
budipine
treatment
nervous system
inflammatory disorders
inn
Prior art date
Application number
PCT/EP1998/004457
Other languages
German (de)
English (en)
Other versions
WO1999004793A2 (fr
Inventor
Thomas Mueller
Reijko Krueger
Wilfried Kuhn
Horst Przuntek
Original Assignee
Byk Gulden Lomberg Chem Fab
Thomas Mueller
Reijko Krueger
Wilfried Kuhn
Horst Przuntek
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chem Fab, Thomas Mueller, Reijko Krueger, Wilfried Kuhn, Horst Przuntek filed Critical Byk Gulden Lomberg Chem Fab
Priority to AU89765/98A priority Critical patent/AU8976598A/en
Publication of WO1999004793A2 publication Critical patent/WO1999004793A2/fr
Publication of WO1999004793A3 publication Critical patent/WO1999004793A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

L'invention concerne une nouvelle utilisation du principe actif budipine (INN) dans le traitement d'affections inflammatoires du système nerveux.
PCT/EP1998/004457 1997-07-23 1998-07-17 Budipine s'utilisant dans le traitement d'affections inflammatoires du systeme nerveux WO1999004793A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU89765/98A AU8976598A (en) 1997-07-23 1998-07-17 Budipine in the treatment of inflammatory disorders of the nervous system

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19731521.6 1997-07-23
DE1997131521 DE19731521A1 (de) 1997-07-23 1997-07-23 Budipin bei der Behandlung entzündlicher Erkrankungen des Nervensystems

Publications (2)

Publication Number Publication Date
WO1999004793A2 WO1999004793A2 (fr) 1999-02-04
WO1999004793A3 true WO1999004793A3 (fr) 1999-04-08

Family

ID=7836555

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1998/004457 WO1999004793A2 (fr) 1997-07-23 1998-07-17 Budipine s'utilisant dans le traitement d'affections inflammatoires du systeme nerveux

Country Status (3)

Country Link
AU (1) AU8976598A (fr)
DE (1) DE19731521A1 (fr)
WO (1) WO1999004793A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6808902B1 (en) 1999-11-12 2004-10-26 Amgen Inc. Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules
US7364736B2 (en) 2001-06-26 2008-04-29 Amgen Inc. Antibodies to OPGL

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996031208A2 (fr) * 1995-04-05 1996-10-10 Byk Gulden Lomberg Chemische Fabrik Gmbh Utilisation de composes de piperidine ou de pyrrolidine substitues pour le traitement de maladies modulees par un recepteur sigma

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996031208A2 (fr) * 1995-04-05 1996-10-10 Byk Gulden Lomberg Chemische Fabrik Gmbh Utilisation de composes de piperidine ou de pyrrolidine substitues pour le traitement de maladies modulees par un recepteur sigma

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JACKISCH R ET AL: "THE ANTIPARKINSONIAN DRUGS BUDIPINE AND BIPERIDEN ARE USE -DEPENDENT (UMCOMPETITIVE) NMDA RECEPTOR ANTAGONISTS", EUROPEAN JOURNAL OF PHARMACOLOGY, vol. 264, no. 2, 1 January 1994 (1994-01-01), pages 207 - 211, XP000607231 *

Also Published As

Publication number Publication date
AU8976598A (en) 1999-02-16
DE19731521A1 (de) 1999-01-28
WO1999004793A2 (fr) 1999-02-04

Similar Documents

Publication Publication Date Title
AU2002234525A1 (en) Transdermal therapeutic system comprising the active ingredient oxybutynin
HUP0000575A3 (en) Novel formulation comprising budesonid as active indegredient
AU2002361811A1 (en) 1,3-bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disorders
WO2000035919A3 (fr) Composes
CA2368843A1 (fr) Pyrimidines substituees neurotrophiques
HK1027280A1 (en) Plant extracts for the treatment of increased boneresorption.
WO2002041889A3 (fr) Composes utiles pour le traitement de troubles du snc
AU8667298A (en) Self-binding shearform compositions
AU2001266152A1 (en) Novel substituted nitrocatechols, their use in the treatment of some central andperipheral nervous system disorders and pharmaceutical compositions containing them
AU2002327097A1 (en) Novel glycolipid and remedial agent for autoimmune disease containing the same as active ingredient
AU2001268422A1 (en) Agmatine and agmatine analogs in the treatment of epilepsy, seizure, and electroconvulsive disorders
WO1999059617A3 (fr) Immunoregulateur
CA2192480A1 (fr) Benzopyrannes et leur utilisation en tant qu'agents therapeutiques
WO1998010762A3 (fr) Formulation a liberation lente de monohydrochlorure de [r-(z)]-alpha-(methoxyimino)-alpha-(1-azabicyclo[2.2.2]oct-3-yl)acetonitrile
WO1998027058A3 (fr) Nouveaux composes
AU4806497A (en) Glyoxylic compound comprising one or more active ingredient
ZA968134B (en) The production of vitamin-containing solid formulations.
WO2001057042A3 (fr) Derives de pyrrole 4-pyridyl- et 2,4-pyrimidinyl-substitues et leur utilisation en pharmacie
WO1999059523A3 (fr) Compositions pharmaceutiques topiques utiles dans le traitement de pathologies cutanees ou circulatoires sur une base inflammatoire, immune, proliferative ou degenerative
ZA972180B (en) Topical formulations for the treatment of psoriasis of the nail.
WO2000053182A3 (fr) 3-cyclopropylmethoxy-4-difluoromethoxy-n-(3,5-dichloropyrid-4-yl)benzamide pour le traitement de la sclerose en plaques
WO1999004793A3 (fr) Budipine s'utilisant dans le traitement d'affections inflammatoires du systeme nerveux
WO2002046225A3 (fr) Utilisation de sarp-1 dans le traitement et/ou la prevention de la sclerodermie
AU8269998A (en) Phosphatidylinositol 4,5-bisphosphate 5-phosphatase from human
AU4136897A (en) 2,3-dihydrobenzofuran derivative and hepatopathy remedy comprising the same as active ingredient

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AU BA BG BR CA CN CZ EE GE HR HU ID IL JP KR LT LV MK MX NO NZ PL RO SG SI SK TR UA US VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

AK Designated states

Kind code of ref document: A3

Designated state(s): AL AU BA BG BR CA CN CZ EE GE HR HU ID IL JP KR LT LV MK MX NO NZ PL RO SG SI SK TR UA US VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
NENP Non-entry into the national phase

Ref country code: KR

NENP Non-entry into the national phase

Ref country code: CA

122 Ep: pct application non-entry in european phase